Yangqi Gu
I am a scientist and biotech entrepreneur working at the intersection of structural biology, synthetic biology, and AI-driven drug discovery. I am driven equally by curiosity about how biological systems work and by a commitment to translating that understanding into real therapies for patients.Across my research career, I have contributed to several breakthroughs, including foundational […]
Sara M. Elkashef, PhD, PharmD
Tumor biology and oncology drug-discovery leader with more than 14 years of experience advancing cancer therapeutic programs across tumor-intrinsic biology, target discovery and validation, oncogenic signaling, cancer genomics-informed research, in vitro and in vivo oncology models, precision oncology, immuno-oncology, radiopharmaceuticals, biologics, small molecules, and gene-editing platforms. Proven record leading discovery and translational studies that define […]
MEHDI SOLEYMANI-GOLOUJEH, Ph.D.
Postdoctoral scientist with 2+ years of post-PhD experience designing and characterizing engineered human pluripotent stem cell lines at the UCSF Diabetes Center. Applies CRISPR/Cas9-based genome engineering, HDR-oriented knock-in/knockout strategies, TALEN-related workflows, and lentiviral effector systems to build hPSC-derived models of inflammation-driven cell death, with multi-lineage differentiation experience relevant to neural and microglial lineage workflows used […]